研究单位：[1]Chia Tai Tianqing Pharmaceutical Group Co., Ltd.[2]Anhui Provincial Hospital,Hefei,Anhui,China,230001[3]The Second Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China,230601[4]Beijing Chao-Yang Hospital, Capital Medical University,Beijing,Beijing,China,100016[5]Beijing Obstetrics and Gynecology Hospital, Capital Medical University,Beijing,Beijing,China,100016[6]Peking Union Medical College Hospital,Beijing,Beijing,China,100730[7]Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital,Beijing,Beijing,China,101100[8]Beijing Luhe Hospital Capital Medical University,Beijing,Beijing,China,101149[9]Chongqing University Cancer Hospital,Chongqing,Chongqing,China,400030[10]Gansu Provincial Hospital,Lanzhou,Gansu,China,730000[11]Lanzhou University Second Hospital,Lanzhou,Gansu,China,730030[12]Gansu Province Maternity and Chid-care Hospital,Lanzhou,Gansu,China,730050[13]Sun Yat-sen University Cancer Center,Guangzhou,Guangdong,China,510080[14]Sun Yat-sen Memorial Hospital, Sun Yat-sen University,Guangzhou,Guangdong,China,510289[15]Guangxi Medical University Affiliated Tumor Hospital,Nanning,Guangxi,China,530022[16]Affiliated Hospital of Hebei University,Baoding,Hebei,China,071002[17]Henan Cancer Hospital,Zhengzhou,Henan,China,4500003[18]Hunan Cancer Hospital,Changsha,Hunan,China,410013[19]Nanjing Drum Tower Hospital,Nanjing,Jiangsu,China,210009[20]Liaoning Cancer Hospital,Shenyang,Liaoning,China,110041[21]Binzhou Medical University Hospital,Binzhou,Shandong,China,256600[22]Linyi Cancer Hospital,Linyi,Shandong,China,276034[23]Qingdao Central Hospital,Qingdao,Shandong,China,266042[24]Weifang People's Hospital,Weifang,Shandong,China,261000[25]Yantai Yuhuangding Hospital,Yantai,Shandong,China,264000[26]Obstetrics & Gynecology Hospital of Fudan University,Shanghai,Shanghai,China,200090[27]Fudan University Shanghai Cancer Center,Shanghai,Shanghai,China[28]Second Hospital of Shanxi Medical University,Taiyuan,Shanxi,China,030001[29]Xi'an People's Hospital,Xi'an,Shanxi,China,710004[30]First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shanxi,China,710061[31]Tianjin Central Hospital of Gynecology Obstetrics,Tianjin,Tianjin,China,300052[32]Tianjin Medical University Cancer Institute & Hospital,Tianjin,Tianjin,China,300060[33]First Affiliated Hospital, School of Medicine, Shihezi University,Shihezi,Xinjiang Uygur Autonomous Region,China,832008[34]The First Affiliated Hospital of Xinjiang Medical University,Urumqi,Xinjiang Uygur Autonomous Region,China,830000[35]Xinjiang Medical University Affiliated Tumor Hospital,Urumqi,Xinjiang Uygur Autonomous Region,China,830000[36]Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China,310000[37]Taizhou Hospital of Zhejiang Province,Taizhou,Zhejiang,China,317000
研究目的：
This is a study to evaluate the efficacy and safety of TQB2450 injection or combined with anlotinib hydrochloride capsule in the treatment of recurrent or metastatic advanced endometrial cancer.
